ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,779,422 | -24.6% | 537,359 | +6.0% | 0.13% | -34.0% |
| Q2 2023 | $14,303,034 | +112.9% | 507,020 | +29.8% | 0.19% | +105.4% |
| Q1 2023 | $6,718,010 | +257.5% | 390,582 | +859.3% | 0.09% | +304.3% |
| Q1 2022 | $1,879,000 | -33.1% | 40,714 | -37.1% | 0.02% | -28.1% |
| Q1 2021 | $2,808,000 | +367.2% | 64,718 | +459.4% | 0.03% | +540.0% |
| Q4 2020 | $601,000 | -5.2% | 11,570 | -40.4% | 0.01% | -61.5% |
| Q3 2020 | $634,000 | – | 19,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |